Chondroitin Sulfate CS b-Bioactive Delays the Progression of Knee Osteoarthritis, Study Finds

beadbb9b-265e-4f43-972f-34f9381b5b8carticleimage.jpg

28 Jun 2017 --- Bioiberica’s Chondroitin sulfate CS b-Bioactive delays osteoarthritis progression and is as effective as the anti-inflammatory drug celecoxib at improving the disease’s symptoms. These are the main conclusions of a clinical essay presented by Professor Jean Pierre Pelletier at the Annual European Congress of Rheumatology, held in Madrid. Conducted by Bioiberica, the MOSAIC clinical essay (a 24-month study on structural changes in knee osteoarthritis assessed by MRI with Chondroitin sulfate) is a multicenter, randomized, double-blind, controlled and comparative study, carried out in five medical centers in Quebec (Canada).

A total of 194 patients suffering from knee osteoarthritis with inflammation (synovitis) and moderate pain participated in the study to assess the effects of chondroitin sulfate (1.200 mg/day) and celecoxib (200 mg day) over the loss of cartilage volume in knee osteoarthritis after 24 months. 

The participants underwent three Quantitative Magnetic Resonance scans: one at the beginning of the study, the second one after one year and a third one at the end of the study. The results revealed that the progression of knee osteoarthritis is slower in patients who received chondroitin sulfate CS b-Bioactive. This group experienced a statistically significant lower loss of cartilage volume as soon as after the first year of treatment, in comparison with those patients who received the anti-inflammatory drug.

Patients treated with chondroitin sulfate had a decrease in synovitis which was associated with a statistically significant decrease in cartilage loss. In addition to that, a post hoc analysis of this clinical trial concludes that chondroitin sulfate also has a protective effect by reducing the long-term progression of knee OA structural changes caused by a decrease in the loss of subchondral bone curvature. 

“This data proves that chondroitin sulfate may delay the advance of osteoarthritis in the long term, and identifies a possible new mode of action of chondroitin sulfate,” Professor Pelletier said. 

The MOSAIC study also evaluated the effects of both products on the disease’s symptoms. Among others, the study evaluated their effects on pain, function, stiffness, joint swelling and effusion; concluding that both treatments were equally efficient across the entire study, reaching a clinically relevant symptom improvement of around 50 percent.

“The study confirms that both products are effective for the treatment of osteoarthritis symptoms, although only chondroitin sulfate has the additional advantage of exerting a joint protection effect,” Professor Pelletier concludes.

To contact our editorial team please email us at editorial@cnsmedia.com

Bioiberica S.A.U.

Collapse

Bioiberica is a biotechnology company specialized in the research, development, production and distribution of biomolecules such as Chondroitin Sulfate, Glucosamine and Hyaluronic Acid for the nutraceutical, pharmaceutical and food industries.

Since 1975, Bioiberica has consolidated its position as an international leader in joint health, thanks to a constant dedication to science and technology.  

Vertically integrated, from the active ingredient to the finished product, Bioiberica places all its medical, scientific and marketing knowledge at the client’s disposal to achieve a leading and innovative line of joint care products.

Bioiberica offers a wide range of innovative and scientifically based branded ingredients for mobility and joint health.

MOBILEE® the First Health Ingredient for Mobility



Mobilee® is an innovative branded ingredient for joint mobility and muscular strength.
It is a patented natural ingredient with a unique composition rich in hyaluronic acid, collagen and other polysaccharides.

The efficacy of Mobilee® in improving joint mobility and muscle strength has been demonstrated in four double blind placebo-controlled randomized clinical trials.

Due to its excellent safety profile, Mobilee® has been approved as Novel Food by the EFSA and has the GRAS status in the USA.

Thanks to its low dose Mobilee® is easy to formulate and can be easily combined with other ingredients.

Mobilee® has been researched and developed by Bioiberica, the Joint Health expert.



b-2Cool® is a natural ingredient supplying native type II collagen.

Thanks to its native form, orally taken b-2Cool works through an immune-mediated mechanism of action called ORAL TOLERANCE, that modulates the immune response against endogenous type II collagen.

It allows b-2Cool® to reduce cartilage degradation and joint inflammation, thus improving joint pain and function.

Tendofit® is a proprietary complex with a unique formula especially designed for tendon health and recovery. 

More that 6 scientific studies support its effectiveness.

Clinical benefits of Tendofit®

Tendon structure recovery

Pain relief

Anti-inflammatory effect

Fast return activity

CS b-Bioactive® is #1 researched chondroitin. Its efficacy has been tested in +20 clinical studies and +5,000 patients.

CS b-Bioactive® has demonstrated to be better absorbed and have higher biological effects compared to other chondroitins.

It is manufactured to the highest pharmaceutical standards, being the reference standard of EP & USP.


Acti-Joint® is a proprietary formula that has demonstrated a superior effect compared to the standard combination Glucosamine 1,500 mg. - Chondroitin 1,200 mg.

Acti-Joint® composition:

b-Glu (Bioiberica’s glucosamine) 1,500 mg

CS b-Bioactive® (Bioiberica’s chondroitin sulfate) 200 mg

Mobilee® (Natural ingredient rich in hyaluronic acid, polysaccharides and collagen) 20 mg

Palbio® is a cartilage complex containing chondroitin sulfate, hydrolyzed collagen and tricalcium phosphate, specially formulated to supply the main components of the joint in directly related nutritional values.

The unique, carefully studied composition of Palbio nourishes the joint and improves its metabolism.

Related Articles

Health & Nutrition News

Vegetables matter: Kale, cabbage and broccoli linked to reduced risk of colon cancer, study finds

21 Aug 2018 --- Chemicals produced by vegetables such as kale, cabbage and broccoli could help to maintain a healthy gut and prevent colon cancer, a new study from the Francis Crick Institute has found. The research, published in Immunity, shows that mice fed on a diet rich in indole-3-carbinol (I3C) – which is produced when we digest cruciferous vegetables – were protected from gut inflammation and colon cancer. While the benefits of eating vegetables are well known, so far, many of the underlying mechanisms remained elusive.

Health & Nutrition News

Watch this space: Screen time drives opportunities for natural eye health solutions

20 Aug 2018 --- Technological advancements have made many aspects of modern life more convenient but also brought certain negative consequences to human health. One of these is the deterioration of eyesight due to increased screen time. What are some of the opportunities and ingredients suppliers are tipping to counteract these effects?

Health & Nutrition News

Consuming milk at breakfast found to lower blood glucose throughout the day

20 Aug 2018 --- Consuming milk with breakfast cereal helps reduce postprandial blood glucose concentration compared with water, while a high dairy protein concentration also reduces postprandial blood glucose concentration compared with normal dairy protein concentration, according to a new study published in the Journal of Dairy Science. The high-protein treatment also decreased appetite after the second meal compared with the low-protein equivalent. As a result, this breakfast routine may provide benefits for the management of Type 2 diabetes, the researchers say. 

Health & Nutrition News

Asia Pacific “diabesity”: Researchers assess strategies to tackle the threat

20 Aug 2018 --- Obesity rates among children in the Asia Pacific are growing at a rapid rate and will soon pose a serious healthcare threat to countries in the region if no action is taken, according to a recent warning by the United Nations’ Food and Agriculture Organization (FAO). To combat the threat of “diabesity” – a term used to describe the close relationship between Type 2 diabetes and obesity – governments and families need to encourage healthier diets, more active living and stress management exercises, says Dr. Naaznin Husein, President of the Indian Dietetic Association’s (IDA) Mumbai chapter. 

Health & Nutrition News

Mushrooms hold potential for prebiotic diabetes treatment, study finds

17 Aug 2018 --- Eating white button mushrooms can create subtle shifts in the microbial community in the gut, which could improve the regulation of glucose in the liver, according to a team of Penn State College of Agricultural Sciences researchers. They also suggest that better understanding this connection between mushrooms and gut microbes in mice could one day pave the way for new diabetes treatments and prevention strategies for people.

More Articles
URL : http://www.nutritioninsight.com:80/news/chondroitin-sulfate-cs-b-bioactive-delays-the-progression-of-knee-osteoarthritis-study-finds.html